Response predictors to treatment with pegylated interferon in chronic hepatitis B
Braz. j. infect. dis
;
14(5): 519-525, Sept.-Oct. 2010. tab
Artículo
en Inglés
| LILACS
| ID: lil-570570
ABSTRACT
The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease have been studied, both before and during the course of medication. Therapy stopping rules have been proposed, which may be useful in patients presenting poor treatment tolerance. This review discusses the treatment response predictors usefulness, with emphasis on ALT, quantitative HBsAg and HBeAg, quantitative HBV-DNA and HBV genotype.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Antivirales
/
Polietilenglicoles
/
Virus de la Hepatitis B
/
Interferón-alfa
/
Hepatitis B Crónica
Tipo de estudio:
Estudio pronóstico
/
Factores de riesgo
Límite:
Humanos
Idioma:
Inglés
Revista:
Braz. j. infect. dis
Asunto de la revista:
Enfermedades Transmisibles
Año:
2010
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS